| Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer A Ward, A Balwierz, JD Zhang, M Küblbeck, Y Pawitan, T Hielscher, ... Oncogene 32 (9), 1173-1182, 2013 | 333 | 2013 |
| MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F S Jurmeister, M Baumann, A Balwierz, I Keklikoglou, A Ward, S Uhlmann, ... Molecular and cellular biology 32 (3), 633-651, 2012 | 287 | 2012 |
| miR-200bc/429 cluster targets PLCγ1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer S Uhlmann, JD Zhang, A Schwäger, H Mannsperger, Y Riazalhosseini, ... Oncogene 29 (30), 4297-4306, 2010 | 259 | 2010 |
| Global microRNA level regulation of EGFR‐driven cell‐cycle protein network in breast cancer S Uhlmann, H Mannsperger, JD Zhang, EÁ Horvat, C Schmidt, ... Molecular systems biology 8 (1), 570, 2012 | 230 | 2012 |
| MicroRNA‐519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour‐suppressor genes in ER+ breast cancer A Ward, K Shukla, A Balwierz, Z Soons, R König, Ö Sahin, S Wiemann The Journal of pathology 233 (4), 368-379, 2014 | 133 | 2014 |
| Click chemistry enables preclinical evaluation of targeted epigenetic therapies DS Tyler, J Vappiani, T Cañeque, EYN Lam, A Ward, O Gilan, YC Chan, ... Science 356 (6345), 1397-1401, 2017 | 131 | 2017 |
| The calcium-binding protein S100P in normal and malignant human tissues S Parkkila, P Pan, A Ward, A Gibadulinova, I Oveckova, S Pastorekova, ... BMC clinical pathology 8, 1-9, 2008 | 118 | 2008 |
| Functional interdependence of BRD4 and DOT1L in MLL leukemia O Gilan, EYN Lam, I Becher, D Lugo, E Cannizzaro, G Joberty, A Ward, ... Nature structural & molecular biology 23 (7), 673-681, 2016 | 103 | 2016 |
| MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer K Shukla, AK Sharma, A Ward, R Will, T Hielscher, A Balwierz, C Breunig, ... Molecular oncology 9 (6), 1106-1119, 2015 | 89 | 2015 |
| Evaluation of storage tubes for combined analysis of circulating nucleic acids in liquid biopsies A Ward Gahlawat, J Lenhardt, T Witte, D Keitel, A Kaufhold, KK Maass, ... International journal of molecular sciences 20 (3), 704, 2019 | 58 | 2019 |
| Differential response to α-oxoaldehydes in tamoxifen resistant MCF-7 breast cancer cells N Nass, HJ Brömme, R Hartig, S Korkmaz, S Sel, F Hirche, A Ward, ... PLoS One 9 (7), e101473, 2014 | 34 | 2014 |
| Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor F Haller, JD Zhang, EA Moskalev, A Braun, C Otto, H Geddert, ... International journal of cancer 136 (5), 1013-1023, 2015 | 32 | 2015 |
| BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity GDPG P. Khoueiry, A. Ward Gahlawat, M. Petretich, A. M. Michon, D. Simola, E ... Epigenetics & Chromatin, 2019 | 20 | 2019 |
| A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis AW Gahlawat, T Witte, L Haarhuis, S Schott British journal of cancer 127 (8), 1550-1556, 2022 | 17 | 2022 |
| Global miRNA regulation of a local protein network: Case study with the EGFR-driven cell cycle network in breast cancer S Uhlmann, H Mannsperger, JD Zhang, EÁ Horvát, C Schmidt, ... Molecular Systems Biology 8, 570, 2012 | 11 | 2012 |
| Total circulating microRNA level as an independent prognostic marker for risk stratification in breast cancer TWSS Aoife Ward Gahlawat, Lavinia Fahed British Journal of Cancer, 2022 | 9 | 2022 |
| AAMP is a binding partner of costimulatory human B7-H3 S Ciprut, A Berberich, M Knoll, S Pusch, D Hoffmann, J Furkel, ... Neuro-oncology advances 4 (1), vdac098, 2022 | 8 | 2022 |
| Whole blood transcriptional fingerprints of high-grade glioma and longitudinal tumor evolution under carbon ion radiotherapy M Knoll, M Waltenberger, J Furkel, U Wirkner, AW Gahlawat, I Dokic, ... Cancers 14 (3), 684, 2022 | 4 | 2022 |
| Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer AW Gahlawat, T Witte, P Sinn, S Schott Scientific Reports 13 (1), 5503, 2023 | 2 | 2023 |
| Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study A Schuhn, TW Tobar, AW Gahlawat, J Hauke, L Baumann, JG Okun, ... Archives of Gynecology and Obstetrics 306 (5), 1623-1632, 2022 | 2 | 2022 |
